Jabra Enhance Select 700 vs ReSound OMNIA miniRIE

The Jabra Enhance Select 700 is a premium-priced OTC hearing aid available at $1,795, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #26 of 65 OTC hearing aids tested, placing it in the top 38% of the category. In our testing, the Enhance Select 700 showed notable strengths in comfort-related metrics. Own-voice comfort scored a solid 3.7/5, measuring 1.19 points above the category average—a meaningful advantage for wearers sensitive to the sound of their own voice. Feedback handling was excellent at 5.0/5, well above the 4.54 category average, indicating reliable stability during typical wear. Speech performance presented a mixed picture. Speech in quiet scored a solid 3.1/5, sitting 0.27 points above average. However, speech in noise was a weakness at 1.0/5, falling 0.48 points below the category average—an important consideration if challenging listening environments are a priority. Music streaming scored 2.5/5, which is above the category average by 0.58 points but only mixed in absolute terms. At this price point, several alternatives delivered stronger overall performance in our testing, including the Lucid Tala (4.61/5) and Audicus Omni 2 (4.59/5). The Jabra Enhance Select 300 and Lucid Engage also achieved higher scores at lower prices. The Enhance Select 700 may suit those prioritizing own-voice comfort and feedback stability over speech-in-noise performance, but shoppers should weigh these trade-offs carefully given the premium pricing.

The ReSound OMNIA miniRIE is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,764. In our lab testing, it earned a SoundScore of 4.0/5 (A grade), ranking #26 of 39 prescription hearing aids tested. This device demonstrates solid speech clarity in quiet environments, scoring 3.7/5—0.26 points above the category average. Own-voice comfort also measures slightly above average at 2.9/5. However, the OMNIA miniRIE struggles in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, which is 1.11 points below the category average and low in absolute terms. This represents a significant limitation for users who frequently encounter noisy environments like restaurants or social gatherings. Feedback handling is strong in absolute terms at 4.1/5, though this falls 0.62 points below the prescription hearing aid category average of 4.72/5. Music streaming performance is mixed at 2.7/5, essentially matching the category average. The device offers modern connectivity features including iPhone and Android streaming, hands-free calling, and rechargeable batteries. While the OMNIA miniRIE has earned Expert's Choice Awards in 2023 and 2024, consumers in this premium price tier should note that several competitors—including the Phonak Sphere Infinio and Oticon Intent—achieve higher overall scores. This hearing aid may be best suited for individuals who prioritize performance in quieter settings and value ReSound's ecosystem, but those needing robust noise management should explore alternatives.